BCL2 and lymphoma: In this study, targeted deep sequencing of 128 highly lymphoma-relevant genes was applied to identify pathogenic variants and CNVs in 26 patients with DLBCL-NOS involving the ocular adnexa and 2 patients with HGBCL with MYC and BCL2 rearrangements.